Related Experiment Videos
[Pregnancy-related thrombocytosis]
Viggo Jønsson1, Johannes E Bock, Tine Helene Mortensen
1Gynaekologisk obstetrisk afdeling Y 4032, Juliane Marie Center, H:S Rigshospitalet, DK-2100 København ø.
Ugeskrift for Laeger
|September 6, 2002
Summary
Pregnancy-related thrombocythaemia, a platelet disorder, can lead to serious maternal and fetal complications. Early identification of risk groups is crucial for better pregnancy outcomes.
Area of Science:
- Hematology
- Obstetrics
- Pathology
Context:
- Pregnancy-associated thrombocythaemia presents as myeloproliferative or reactive subsets.
- Myeloproliferative thrombocythaemia in pregnancy is linked to poor fetal and maternal outcomes.
- Reactive thrombocythaemia can be physiological postpartum or inflammatory due to necrosis.
Purpose:
- To differentiate between myeloproliferative and reactive thrombocythaemia in pregnancy.
- To highlight the risks associated with pregnancy-related thrombocythaemia.
- To emphasize the need for awareness of risk groups for timely intervention.
Summary:
- Myeloproliferative thrombocythaemia in pregnancy results in high rates of unsuccessful deliveries (50-70%) and significant maternal (arterial/venous thrombosis) and fetal (abruptio placentae, pre-eclampsia, fetal death) complications.
- Physiological postpartum reactive thrombocythaemia is generally benign.
- Inflammatory reactive thrombocythaemia, linked to severe necrosis, involves a moderate platelet rise and is less associated with thromboembolic events.
Impact:
- Highlights the critical need for monitoring platelet counts in high-risk pregnancies.
- Informs clinical practice regarding the management of pregnancy-related thrombocythaemia.
- Aims to improve fetal survival rates and reduce maternal morbidity in affected pregnancies.